Health System

Latest News

ROS1-positive NSCLC is aggressive and rare, with approximately 3000 new diagnoses of advanced disease in the US each year. | Image credit: appledesign - stock.adobe.com
Taletrectinib Recommended in NCCN Guidelines for ROS1-Positive NSCLC

July 31st 2025

Taletrectinib was added to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology as a preferred option for the first-line and subsequent treatment of advanced ROS1-positive non–small cell lung cancer (NSCLC).

Stethoscope with health icons next to a white piggy bank | Image credit: Kiattisak - stock.adobe.com
Upfront HSCT More Cost-Effective for Patients With AML in Remission

July 31st 2025

AJMC
Managed Care Reflections: A Q&A With Charles N. (Chip) Kahn III, MPH

July 30th 2025

CMS Adminstrator Mehmet Oz, MD, MBA, speaks with AtlantiCare CEO Michael Charlton, MHL, during a visit to Atlantic City.
As CMS Embarks on “Rural Transformation,” a New Jersey Health System Weighs In

July 19th 2025

Robin Zon, MD | Image: ASCO
Building a Better Future Through Technology, Advocacy, and Community

July 17th 2025

More News

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo